Greater collaboration and trade opportunities will be the focus of an international trade mission taking place later this month. The City of Mentor, in Northeast Ohio, will host a delegation of Midlands Life Science companies from October 22 to October 24. This will help promote trade and investment between the...
Maetrics brings EU Medical Device Regulation expertise to the 2018 American Medical Device Summit
Peter Rose, Managing Director for Maetrics in Europe will be speaking at the upcoming American Medical Device Summit on 25 October at 12.35pm about the new Medical Device Regulation (MDR) in Europe. With 25 years of experience in the medical device industry, Mr Rose will be bringing his depth of...
New technology transfer network set to accelerate innovation in the Midlands
The Midlands Innovation group of universities has launched the largest collaboration between university technology transfer offices in the UK, to attract investment and management talent to the region. The Midlands Innovation Commercialisation of Research Accelerator (MICRA) will share best practice and share resources across technology transfer offices in Midlands universities....
€3.16million for European Life Science Businesses
Life science businesses can learn all about new plans to improve personalised healthcare, at an Interreg North-West Europe event, hosted by the University of Leicester and supported by Medilink Midlands. The free CoDex4SMEs roadshow will take place on Thursday, October...
Possible impact of no-deal Brexit on EU IP rights
How would a no-deal Brexit affect the protection of EU intellectual property rights in the UK? The UK government issued guidance on 24 September 2018 confirming that EU trade mark and design rights will continue to be protected in the UK in the event of a no-deal Brexit. The UK...
XenoGesis opens new laboratories and offices at BioCity’s Discovery Building
Leading DMPK/ADME provider, XenoGesis has celebrated the official opening of its new laboratories and offices at BioCity Nottingham’s state-of-the-art Discovery Building. Founded in 2011 by Richard Weaver, XenoGesis is an independent laboratory-based contract research organisation specialised in preclinical drug metabolism and pharmacokinetics (DMPK), quantitative bioanalysis, in vitro pharmacology and modelling...
BioHub Birmingham® develops new incubator space to meet increasing demand for biomedical facilities
The BioHub Birmingham® is constructing 5,000sq ft of self-contained laboratory and office suites to meet an increasing demand for biomedical incubator space. The BioHub opened in 2015 and its shared facilities on the ground floor are now operating at capacity. It is managed by University of Birmingham Enterprise and is...
Maetrics Shine a Spotlight on Clinical Evaluation Reports in the Medical Device Industry
New Maetrics whitepaper highlights the compliance changes to CERs in light of the new EU Medical Device Regulations and how to navigate them Maetrics, a leading international life sciences regulatory and compliance consultancy, have launched a new report providing clarity to medical device manufacturers on the requirements for properly documented,...
Derby medical devices firm to spearhead UK-Texas trade deal
Derby medical devices firm, SurePulse is spearheading a new UK-Texas life sciences trade deal that the government says will provide direct access to the largest medical complex in the world. The Department for International Trade (DIT) have announced that it has agreed a landmark ‘BioBridge’ collaboration with the Texas Medical...
Pharmaceuticals business honoured by Board of Trade Award
A Pharma business is one of nine in the Midlands to receive a Board of Trade Award, from the Department for International Trade. At a special ceremony Dr Nik Kotecha OBE, Chief Executive of Morningside Pharmaceuticals Ltd, which is based in Loughborough, received the award from Secretary of State, Dr...
